Lymphobank Research, a biotech that advances research and health

Hosted first at the French Blood Establishment (EFS) then at the Bio Innovation development center, Lymphobank biotechnology company since June has occupied new premises at Bioparc 1, a building dedicated to high-tech medical and biomedical activities.

. “We needed more space to respond to the growth of our business,” reports founding director Éric Robinet. In fact, the company has grown from 1 to 8 employees in barely 5 years. “Originally, I created Lymphobank in order to adapt to the treatment of liver cancer a product initially developed by
EFS to treat leukemia »
summarizes this former EFS researcher. This long-term research project is coupled with an extremely regulated industrial activity: the production of blood cells intended for research.

Recovery / recovery

“From the blood of adult donors, we isolate certain white blood cells, including “killer” cells that give the body its ability to fight infectious diseases and tumors; we purify them and then freeze them” summarizes the scientist. Same principle, same process with placental blood, taken from the umbilical cord after consent of the mother. We work with regional hospitals (Besançon, Dijon, Trévenans). Somehow we
We recover and valorize “waste blood products” and sell them exclusively to research laboratories. » Lymphobank products thus contribute to the progress of
life science.

Others talk about it:
Lymphobank, a new biotech nugget in Besançon

More information !

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.